XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.2
Share-based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation
The following table presents total share-based compensation expense within each functional line item on the condensed consolidated statements of operations for the three and six months ended June 30, 2025 and 2024 (in thousands):
 Three Months Ended
June 30,
Six Months Ended
June 30,
  2025202420252024
Cost of revenues$55 $27 $107 $52 
Research and development266 81 534 241 
Sales and marketing143 46 289 211 
General and administrative1,190 680 2,325 1,017 
Income from discontinued operations, net of tax— 35 — 65 
      Total$1,654 $869 $3,255 $1,586 
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity for the six months ended June 30, 2025:
Outstanding — December 31, 2024269,851 
Granted1,066,300 
Exercised(4,636)
Canceled(48,683)
Outstanding — June 30, 20251,282,832 
Exercisable — June 30, 2025140,174 
Schedule of Stock Options, Valuation Assumptions The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the awards:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)10
Risk-free interest rate4.57 %
Volatility84.00 %
Expected dividend yield— %
The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the Market-based CEO RSUs:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)3
Risk-free interest rate4.25 %
Volatility105.63 %
Expected dividend yield— %
Correlation coefficient0.3741
Schedule of Restricted Stock Unit Activity
The following table summarizes the Company’s RSU activity for the six months ended June 30, 2025:
Non-vested — December 31, 20241,111,841 
Granted359,739 
Vested(51,939)
Forfeited(98,402)
Non-vested — June 30, 20251,321,239